Maternal-Fetal Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
J Obstet Gynaecol Res. 2022 Sep;48(9):2285-2295. doi: 10.1111/jog.15337. Epub 2022 Jul 17.
To systematically review and summarize the available literature regarding the women's sexual function during COVID-19 pandemic and compare it to pre-pandemic period.
We searched PubMed and Embase from the inception of the databases until 15th April 2021. Data regarding the sexual function, measured by female sexual function index (FSFI), of adult sexually active women were extracted from the eligible studies and compared between the before and during the COVID-19 pandemic. The secondary outcome was the frequency of intercourse during pandemic time. The random-effect model was used to pool the mean differences and corresponding 95% confidence intervals (CIs). Heterogeneity was assessed using the I value.
Our search resulted in a sample of six eligible studies, which involved 1114 female participants. The total FSFI score among study participants during pandemic was 22.93 (95% CI: 19.26-26.59), which indicated a significant decrease in sexual function of women during pandemic as compared to pre-pandemic time (mean difference = -3.80, 95% CI: -6.48 to -1.12, p = 0.005, I = 96%). We also conducted a meta-analysis of individual FSFI domains. During pandemic, women had problems with arousal (p < 0.0001), orgasm (p = 0.0008), satisfaction (p = 0.0009), and pain (p = 0.009). No significant difference in frequency of intercourse was observed between pre- and during pandemic (p = 0.80). Furthermore, no significant publication bias was present among included studies.
Overall, there was a significant decrease in sexual function of sexually active adult women during COVID-19 pandemic. The most affected areas of sexual function were arousal, orgasm, pain, and satisfaction. Physicians must be aware of COVID-19 impact on sexual life of women and provide proper counseling.
系统回顾和总结了关于 COVID-19 大流行期间女性性功能的现有文献,并将其与大流行前时期进行了比较。
我们从数据库创建之初到 2021 年 4 月 15 日在 PubMed 和 Embase 中进行了检索。从合格研究中提取了有关成年有性生活的女性性功能的信息,这些信息通过女性性功能指数(FSFI)进行测量,并将其与 COVID-19 大流行前后进行了比较。次要结果是大流行期间性交的频率。使用随机效应模型汇总均值差异及其相应的 95%置信区间(CI)。使用 I 值评估异质性。
我们的搜索结果是 6 项合格研究的样本,涉及 1114 名女性参与者。大流行期间研究参与者的总 FSFI 评分为 22.93(95%CI:19.26-26.59),这表明与大流行前相比,女性的性功能在大流行期间明显下降(平均差异= -3.80,95%CI:-6.48 至-1.12,p=0.005,I ²=96%)。我们还对各个 FSFI 领域进行了荟萃分析。在大流行期间,女性出现了性欲(p<0.0001)、性高潮(p=0.0008)、满足感(p=0.0009)和疼痛(p=0.009)问题。在大流行前和大流行期间,性交频率没有明显差异(p=0.80)。此外,纳入的研究中没有明显的发表偏倚。
总体而言,在 COVID-19 大流行期间,有性生活的成年女性的性功能明显下降。性功能受影响最严重的领域是性欲、性高潮、疼痛和满足感。医生必须意识到 COVID-19 对女性性生活的影响,并提供适当的咨询。